West to Host Fourth-Quarter and Full-Year 2025 Conference Call

Company Overview - West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services, supporting both established and emerging drug developers [4] - The company has over 10,000 team members across 50 sites, including 25 manufacturing facilities worldwide, delivering over 41 billion components and devices each year [4] - In fiscal year 2024, West generated $2.89 billion in net sales and is traded on the New York Stock Exchange (NYSE: WST) [5] Upcoming Financial Results - West Pharmaceutical Services will release its fourth-quarter and full-year 2025 financial results before the market opens on February 12, 2026 [1] - A conference call to discuss the results and business expectations will take place at 8:00 a.m. Eastern Time on the same day [1] Investor Engagement - A live webcast of the conference call will be available, and participants must register in advance to ask questions [2] - A slide presentation will be accessible in the Investors section of the company's website on the day of the call, with a replay available for approximately 90 days after the event [3]